DEKODA BOST: Open Payments
NPI 1952609885 · YUKON, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,007 in 109 payments from 20 companies in 2025. Trend: 2023 $1,840 · 2024 $1,673 · 2025 $2,007
Food & beverage: $1,930Education: $77
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 19 | $278 |
| ABBVIE INC. | 15 | $265 |
| Lilly USA, LLC | 12 | $245 |
| AstraZeneca Pharmaceuticals LP | 6 | $170 |
| HARMONY BIOSCIENCES LLC | 4 | $162 |
| Novo Nordisk Inc | 12 | $155 |
| GlaxoSmithKline, LLC. | 12 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $106 |
| SHIELD THERAPEUTICS INC | 3 | $94 |
| Exact Sciences Corporation | 4 | $69 |
Products named: PREVNAR 20, MOUNJARO, TRELEGY ELLIPTA, AIRSUPRA, JARDIANCE, CAPLYTA, ACCRUFER, VRAYLAR.
Industry payments across OK — which companies pay providers there.
